Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 2008-2020

  Nasrolahi Shirazi, Amir ^a   Tiwari, Rakesh Kumar ^a   Oh, Donghoon ^a   Banerjee, Antara ^b   Yadav, Arpita ^b   Parang, Keykavous ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b CSJM UNIVERSITY   (India)

Author keywords

cellular uptake; cyclic peptides; nanoparticles; phosphopeptides; SH2 domain

Indexed keywords

ARGININE; FLUORESCEIN; PHOSPHOPEPTIDE; TRYPTOPHAN; CYCLOPEPTIDE; DRUG CARRIER; FLUORESCENT DYE; SURFACTANT;

ARTICLE; CALORIMETRY; CELL MEMBRANE PERMEABILITY; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; ENTROPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; ISOTHERM; ISOTHERMAL CALORIMETRY; LEUKEMIA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSMISSION ELECTRON MICROSCOPY; ACTIVE TRANSPORT; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN DOMAIN; THERMODYNAMICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ARGININE; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; PHOSPHOPEPTIDES; PROTEIN INTERACTION DOMAINS AND MOTIFS; SURFACE-ACTIVE AGENTS; THERMODYNAMICS; TRYPTOPHAN;

EID: 84877288193     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400046u     Document Type: Article

References (44)

1. Bulut, S.; Erkal, T. S.; Toksoz, S.; Tekinay, A. B.; Tekinay, T.; Guler, M. O. Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers Biomacromolecules 2011, 12, 3007-3014
2. Kim, J. K.; Anderson, J.; Jun, H. W.; Repka, M. A.; Jo, S. Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery Mol. Pharmaceutics 2009, 6, 978-85
3. Dheur, S.; Dias, N.; Van Aerschot, A.; Herdewijn, P.; Bettinger, T.; Rémy, J. S.; Hélène, C.; Saison-Behmoaras, E. T. Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleotides Antisense Nucleic Acid Drug Dev. 1999, 9, 515-25
4. Jeong, J. H.; Kim, S. H.; Kim, S. W.; Park, T. G. Intracellular delivery of poly(ethylene glycol) conjugated antisense oligonucleotide using cationic lipids by formation of self-assembled polyelectrolyte complex micelles J. Nanosci. Nanotechnol. 2006, 6, 2790-2795
5. Crombez, L.; Aldrian-Herrada, G.; Konate, K.; Nguyen, G. N.; McMaster, G. K; Brasseur, R.; Heitz, G. K.; Divita, G. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells Mol. Ther. 2008, 17, 95-103
6. El-Andaloussi, S.; Holm, T.; Langel, U. Cell-penetrating peptides: mechanisms and applications Curr. Pharm. Des. 2005, 11, 3597-3611
7. Fotin-Mleczek, M.; Fischer, R.; Brock, R. Endocytosis and cationic cell-penetrating peptides - a merger of concepts and methods Curr. Pharm. Des. 2005, 11, 3613-3628
8. Fernandez-Carneado, J.; Kogan, M. J.; Pujals, S.; Giralt, E. Amphipathic peptides and drug delivery Biopolymers 2004, 76, 196-203
9. Deshayes, S.; Morris, M. C.; Divita, G.; Heitz, F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics Cell. Mol. Life Sci. 2005, 62, 1839-1849
10. Torchilin, V. P.; Rammohan, R.; Weissig, V.; Levchenko, T. S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 8786-8791
11. Silhol, M.; Tyagi, M.; Giacca, M.; Lebleu, B.; Vives, E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat Eur. J. Biochem. 2002, 269, 494-501
12. Thorén, P. E.; Persson, D.; Isakson, P.; Goksör, M.; Onfelt, A.; Nordén, B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells Biochem. Biophys. Res. Commun. 2003, 307, 100-107
13. Zhou, Y.; Abagyan, R. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains Folding Des. 1998, 3, 513-522
14. Machida, K.; Mayer, B. J. The SH2 domain: versatile signaling module and pharmaceutical target Biochim. Biophys. Acta 2005, 1747, 1-25
15. Songyang, Z.; Shoelson, S. E.; Chaudhuri, M.; Gish, G.; Pawson, T.; Haser, W. G.; King, F.; Roberts, T.; Ratnofsky, S.; Lechleider, R. J.; Neel, B. G.; Birge, R. B.; Fajardo, J. E.; Chou, M. M.; Hanafusa, H.; Schaffhausen, B.; Cantley, L. C. SH2 domains recognize specific phosphopeptide sequences Cell 1993, 72, 767-778
16. Pinna, L. A.; Donella-Deana, A. Phosphorylated synthetic peptides as tools for studying protein phosphatases Biochim. Biophys. Acta 1994, 1222, 415-431
17. Ottinger, E. A.; Shekels, L. L.; Bernlohr, D. A.; Barany, G. Synthesis of phosphotyrosine-containing peptides and their use as substrates for protein tyrosine phosphatases Biochemistry 1993, 32, 4354-4361
18. Burke, T. R.; Yao, Z. J.; Liu, D. G.; Voigt, J.; Gao, Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors Biopolymers 2001, 60, 32-44
19. Eck, M. J. A new flavor in phosphotyrosine recognition Structure 1995, 3, 421-424
20. Dunican, D. J.; Doherty, P. Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways Biopolymers 2001, 60, 45-60
21. Williams, E. J.; Dunican, D. J.; Green, P. J.; Howell, F. V.; Derossi, D.; Walsh, F. S.; Doherty, P. Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide J. Biol. Chem. 1997, 272, 22349-22354
22. Derossi, D.; Williams, E. J.; Green, P. J.; Dunican, D. J.; Doherty, P. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide Biochem. Biophys. Res. Commun. 1998, 251, 148-152
23. Theodore, L.; Derossi, D.; Chassaing, G.; Llirbat, B.; Kubes, M.; Jordan, P.; Chneiweiss, H.; Godement, P.; Prochiantz, A. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse J. Neurosci. 1995, 15, 7158-7167
24. Garrido-Hernandez, H.; Moon, K. D.; Geahlen, R. L.; Borch, R. F. Design and synthesis of phosphotyrosine peptidomimetic prodrugs J. Med. Chem. 2006, 49, 3368-3376
25. Boutselis, I. G.; Yu, X.; Zhang, Z. Y.; Borch, R. F. Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug J. Med. Chem. 2007, 50, 856-864
26. Arrendale, A.; Kim, K.; Choi, J. Y.; Li, W.; Geahlen, R. L.; Borch, R. F. Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity Chem. Biol. 2012, 19, 764-771
27. Panigrahi, K.; Nelson, D. L.; Berkowitz, D. B. Unleashing a "true" pSer-mimic in the cell Chem. Biol. 2012, 19, 666-667
28. Tarrant, M. K.; Rho, H. S.; Xie, Z.; Jiang, Y. L.; Gross, C.; Culhane, J. C.; Yan, G.; Qian, J.; Ichikawa, Y.; Matsuoka, T.; Zachara, N.; Etzkorn, F. A.; Hart, G. W.; Jeong, J. S.; Blackshaw, S.; Zhu, H.; Cole, P. A. Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis Nat. Chem. Biol. 2012, 8, 262-269
29. Goguen, B. N.; Hoffman, B. D.; Sellers, J. R.; Schwartz, M. A.; Imperiali, B. Light-triggered myosin activation for probing dynamic cellular processes Angew. Chem., Int. Ed. 2011, 50, 5667-5670
30. Ye, G.; Nam, N. H.; Kumar, A.; Saleh, A.; Shenoy, D. B.; Amiji, M. M.; Lin, X.; Sun, G.; Parang, K. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides J. Med. Chem. 2007, 50, 3604-3617
31. Mandal, D.; Nasrolahi Shirazi, A.; Parang, K. Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters Angew. Chem., Int. Ed. 2011, 50, 9633-9637
32. Nasrolahi Shirazi, A.; Tiwari, R. K.; Chhikara, B. S.; Mandal, D.; Parang, K. Design and evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs Mol. Pharmaceutics 2013, 10, 488-499
33. Dennington, R., II; Keith, T.; Millan, J.; Eppinnett, K.; Hovell, W. L.; Gilliand, R.; Gaussview, Version 3.09; Semichem Inc.: S. Mission, KS, 2003.
34. Ditchfield, R.; Hehre, W. J.; Pople, J. A. An Extended Gaussian-Type Basis for Molecular-Orbital Studies of Organic Molecules J. Chem. Phys. 1971, 54, 724-728
35. Nam, N. H.; Ye, G.; Sun, G.; Parang, K. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding J. Med. Chem. 2004, 47, 3131-3141
36. Sawyer, T. K. Src homology-2 domains: structure, mechanisms, and drug discovery Biopolymers 1998, 47, 243-261
37. Vu, C. B.; Corpuz, E. G.; Pradeepan, S. G.; Violette, S.; Bartlett, C.; Sawyer, T. K. Nonpeptidic SH2 inhibitors of the tyrosine kinase ZAP-70 Bioorg. Med. Chem. Lett. 1999, 9, 3009-3014
38. Vu, C. B. Recent advances in the design and synthesis of SH2 inhibitors of Src, Grb2 and ZAP-70 Curr. Med. Chem. 2000, 7, 1081-100
39. Muller, G. Peptidomimetics SH2 domain antagonists for targeting signal transduction Top. Curr. Chem. 2000, 211, 17-59
40. Vu, C. B.; Corpuz, E. G.; Merry, T. J.; Pradeepan, S. G.; Bartlett, C.; Bohacek, R. S.; Botfield, M. C.; Eyermann, C. J.; Lynch, B. A.; MacNeil, I. A.; Ram, M. K.; van Schravendijk, M. R.; Violette, S.; Sawyer, T. K. Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70 J. Med. Chem. 1999, 42, 4088-98
41. Cody, W. L.; Lin, Z.; Panek, R. L.; Rose, D. W.; Rubin, J. R. Progress in the development of inhibitors of SH2 domains Curr. Pharm. Des. 2000, 6, 59-98
42. Madani, F.; Lindberg, S.; Langel, U.; Futaki, S.; Gräslund, A. Mechanisms of cellular uptake of cell-penetrating peptides J. Biophys. 2011, 2011, 414729
43. Ball, V.; Maechling, C. Isothermal microcalorimetry to investigate non specific interactions in biophysical chemistry Int. J. Mol. Sci. 2009, 10, 3283-3315
44. Bouchemal, K. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry Drug Discovery Today 2008, 13, 960-972